Initial Data Transfer. Within a reasonable time not to exceed [ * ] following the Effective Date, Sangamo will disclose to Pfizer true, accurate and complete copies of all Licensed Know-How, in each case to the extent developed by Sangamo on or prior to the Effective Date and in such format as Pfizer may reasonably request (including by download of digital files to a secure website or e-room designated and controlled by Pfizer).
Appears in 2 contracts
Sources: Research Collaboration and License Agreement (Sangamo Therapeutics, Inc), Research Collaboration and License Agreement (Sangamo Therapeutics, Inc)